Single Arm Post-marketing Study of SC20 Colonoscope

Stopped early · Phase 4

Conditions studied: Gentle Colonoscopy

In brief

The objective of the study is to gather post-market data regarding the performance of the invendo SC20 colonoscope in a real-world US population.

Key facts

Study ID

NCT02279836

Run by

Invendo Medical GmbH

People needed

2

Starts

2014-10-01

Expected to finish

2016-01-01

Last updated by the study team

2015-02-04

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Any indication for colonoscopy
• Willing to give informed consent
• Willing to consume 2-4 liters of bowel prep

You may not qualify if…

• An age younger than 18 years
• Congestive heart failure
• Renal insufficiency
• Intestinal obstruction
• Any acute life-threatening condition (in the opinion of the investigator)
• Current pregnancy
• Abdominal surgery in the past 6 months
• Bleeding disorders
• Inability to provide informed consent
• Any other contraindication to colonoscopy (e.g. fulminant colitis or acute diverticulitis)

Where it is running

• Bellevue Hospital Center — New York, New York, United States
• NYU Langone Medical Center Ambulatory care — New York, New York, United States
• New York Presbyterian Columbia University Medical Center — New York, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.